Tevogen Report Outlines Plans to Expand Target Population for TVGN 489
Tevogen Bio Holdings Inc. Expands TVGN 489’s Market Potential Tevogen Bio Holdings Inc. (NASDAQ: TVGN) has announced an ambitious expansion plan for its experimental drug, TVGN 489, aiming to include patients aged 65 and older. … Read more